MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-29
DOI
10.1007/s12031-018-1177-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound
- (2018) Daniel Coluccia et al. Nanomedicine-Nanotechnology Biology and Medicine
- A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
- (2018) Eroje M. Ahmed et al. CELLULAR ONCOLOGY
- Down-expression of miR-154 suppresses tumourigenesis in CD133+glioblastoma stem cells
- (2016) Liang Yang et al. CELL BIOCHEMISTRY AND FUNCTION
- The challenges associated with molecular targeted therapies for glioblastoma
- (2016) Toni Rose Jue et al. JOURNAL OF NEURO-ONCOLOGY
- Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells
- (2015) Solange Tréhoux et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
- (2015) O. van Tellingen et al. DRUG RESISTANCE UPDATES
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Incorporating Cancer Stem Cells in Radiation Therapy Treatment Response Modeling and the Implication in Glioblastoma Multiforme Treatment Resistance
- (2015) Victoria Y. Yu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis
- (2015) Mingzhi Han et al. MOLECULAR NEUROBIOLOGY
- Glioblastoma multiforme: Pathogenesis and treatment
- (2015) Constantinos Alifieris et al. PHARMACOLOGY & THERAPEUTICS
- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing
- (2014) Rahul Agrawal et al. BMC GENOMICS
- Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer
- (2013) Min Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
- (2013) Rosa Nadal et al. INTERNATIONAL JOURNAL OF CANCER
- CD133 Is Essential for Glioblastoma Stem Cell Maintenance
- (2013) Paola Brescia et al. STEM CELLS
- Glioblastoma cancer stem cells – From concept to clinical application
- (2012) Barbara E. Stopschinski et al. CANCER LETTERS
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation
- (2010) Kaoru Tamura et al. JOURNAL OF NEUROSURGERY
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started